Human umbilical-vein endothelial cells (HUVECs) were cultured, and their inositol phosphate formation and Ca2l mobilization in response to thrombin and histamine were studied. Evidence from measurement of intracellular Ca2l in the absence of extracellular Ca2l established that the two agonists were both acting on a single cell population, and suggested that a Ca2l-influx component was stimulated which was dependent on receptor-occupancy. After 30 s of stimulation in the presence of 10 mM-LiCl, the effects of 20,Mhistamine and 1 unit of thrombin/ml on formation of inositol phosphates were additive, but at 5 min they were not. HUVECs labelled with myo-[3H]inositol for 72 h synthesized radiolabelled inositol pentakis-and hexakis-phosphate. The predominant isomers of inositol mono-, bis-and tris-phosphates whose formation was stimulated were the 4-phosphate, the 1,4-bisphosphate and the 1,3,4-trisphosphate.
INTRODUCTION
Endothelial cells play a central role in the maintenance of normal vascular homoeostasis, by providing a continuous barrier between the blood circulation and all other body tissues. In response to specific humoral agents, for example histamine, thrombin, bradykinin and ATP, endothelial cells synthesize and secrete prostacyclin [1] [2] [3] [4] , which is a potent vasodilator and an inhibitor of blood platelet activation [5] . Endothelial cells are also reported to contract in response to histamine and thrombin [6, 7] , an effect which would cause an increase in vascular permeability in vivo. Both synthesis of prostacyclin and endothelial-cell contractility are probably controlled by agonist-dependent elevations in cytosolic free Ca2" concentration ([Ca2`]j), the most likely mechanisms being respectively through activation of phospholipase A2 [8] and myosin light-chain kinase.
It is now established that receptor-mediated generation of inositol 1,4,5-trisphosphate [Ins (1, 4, 5) P3] from phosphatidylinositol 4,5-bisphosphate in the plasma membrane is a means by which some hormones and neurotransmitters can promote the discharge of Ca2+ from intracellular stores (for reviews see [9, 10] (1, 4, 5) P3, and an influx component, which recent studies suggest could be controlled, at least in part, by inositol 1,3,4,5-tetrakisphosphate [12, 13] .
While the present experiments were in progress, independent studies appeared which showed that both histamine and thrombin were able to stimulate the prodution of inositol phosphates in HUVECs [14] [15] [16] . In the present study we confirm these observations, and extend them to show that a variety of inositol phosphate isomers are generated during receptor stimulation, that these two agonists are acting on the same cell populations, and that at early time points their effects are additive. Hence, in addition to being cells of interest in their own right with respect to vascular homoeostasis, HUVECs are a cell type well suited to studying the interaction of different receptors coupled to the same intracellular signalling system.
MATERIALS AND METHODS Materials
Human umbilical cords were obtained from the Rosie Maternity Hospital, Cambridge (U.K.). Human thrombin (3000 units/mg), histamine dihydrochloride and collagenase (type II) were from Sigma. Penicillin (5000 units/ml)/streptomycin (5000 ,ug/ml), foetal-calf serum and trypsin (0.05 %)/EDTA (0.02%) were obtained from Flow Laboratories. Medium 199 with Earl's salts, NaHCO3 and L-glutamine was obtained from Gibco.
The acetoxymethyl ester of fura-2 was from Molecular Probes (Junction City, OR, U.S.A.). Accell QMA SEPPAKs (lot no. P5270A1) were from Waters Associates (Harrow, Middx., U.K.). Freon (1,1,2-trichlorotrifluoroethane) and tri-n-octylamine were from BDH. myo- [ 
Preparation of cells
Human umbilical cords (15-20 cm) were collected and stored for up to 12 h at 4°C in medium 199 containing penicillin (50 units/ml)/streptomycin (50 ,ug/ml). Venous endothelial cells were harvested by collagenase digestion as originally described by Jaffe et al. [17] . Briefly, veins were cannulated and flushed with 20 ml of sterile phosphate-buffered saline (138 mM-NaCl, 2.7 mM-KCl, 0.5 mM-MgCl2, 1.47 mM-KH2PO4, 8.1 mMNa2HPO4, pH 7.5). The cord was then clamped at one end, the vein was filled with 10-15 ml of collagenase (0.5 mg/ml dissolved in medium 199), and then the cord was incubated at 37°C for 10 min. Detached endothelial cells were flushed out, harvested by centrifugation (500 g for 5 min at 15-20°C), and the cells were resuspended in 5 Fluorescence studies For fura-2 fluorescence studies, HUVECs on coverslips were incubated for 45 min at 37°C in 2 ml of FSM containing 2 /SM-fura-2-acetoxymethyl ester, as described by Hallam & Pearson [11] . The medium was then aspirated and replaced with 2 ml of Hepes-buffered saline, consisting of 145 mM-NaCl, S mM-KCl, 1 mmMgSO4, 10 mM-Hepes and 10 mM-glucose, pH 7.4, and the cells were kept at room temperature until used. Coverslips were placed diagonally inside a cuvette (5 mm x 10 mm optical path length) containing 1.5 ml of Hepes-buffered saline. The cuvette was then placed in cuvette holder maintained at 37°C in a PerkinElmer MPF 44A spectrofluorimeter with the 10mm face orientated perpendicular to the emission path. Fluorescence was monitored continuously with excitation at 339 nm (6 mm slit width) and emission at 500 nm (10 mm were then calculated exactly as described previously [19] . Production of radiolabelled inositol phosphates For studies of inositol phosphate production in HUVECs, the FSM in 35 mm dishes was replaced with 1 ml of medium 199 containing 5 ,uCi of [3H]inositol, and the cells were incubated at 37°C for 24 h. Alternatively cells were incubated with 2 ,uCi of [3H]inositol for 72 h. After labelling, cells were washed with 2 x 2 ml of Hepesbuffered saline supplemented with 10 mM-LiCl and 1 mM-CaCl2. The cells were preincubated for 5-10 min at 37°C before the buffer was aspirated, and replaced with buffer containing receptor agonists where indicated. Incubations were terminated by aspirating the buffer and adding 1 ml of ice-cold 6 % (v/v) HC104 to the dish, which was placed on ice. After 10 min, the lysed cells were scraped into an Eppendorf Microfuge tube and pelleted by centrifugation (12000 g for 2 min) in an MSE Microfuge; the supernatant was transferred to a conical glass centrifuge tube.
The acid extract was neutralized by the method of Sharpes & McCarl [20] , as described by Wreggett & Irvine [21] , by adding 950,u of the supernatant to 1.8 ml of freshly prepared freon/octylamine (1:1, v/v). At this stage, phytate hydrolysate (25 ,ug of P) was added as recommended by Wreggett et al. [22] . This mixture was then vortex-mixed for 30 s, and then centrifuged (3000 g for 5 min). The upper phase, pH 6-6.5, containing the water-soluble radioactivity was diluted to 4 ml in distilled water and stored at -20°C until analysis. Analysis of radiolabelied inositol phosphates Inositol phosphates extracted from HUVECs were fractionated by anion-exchange chromatography on Accell QMA SEP-PAKs (Waters Associates) as described by Wreggett & Irvine [21] .
Samples were loaded on to a SEP-PAK, previously converted into the formate form, and were batchprocessed by sequential elution with 10 ml each of water, 5 mM-Na2B4O7, 0.1 M-ammonium formate/0.01 Mformic acid/5 mM-Na2B407, 0.2 M-ammonium formate/ 0.02 M-formic acid/5 mM-Na2B407 and 0.3 M-ammonium formate/0.03 M-formic acid/5 mM-Na2B407, followed by S ml of 1 M-ammonium formate/0.1 M-formic acid, to elute inositol, GroPIns, and mono-, bis-, tris-and then higher-phosphorylated forms of inositol respectively. The cartridge was then washed with 10 ml of water and the next sample was loaded. A 3.5 ml portion of each eluted fraction was added to 10 ml of Beckman X12 scintillation fluid, and radioactivity was determined in a Beckham LS2100 liquid-scintillation counter operating at 40 % efficiency. The [24] , and see refs. [25] [26] [27] (Fig. lb) . Whether this is a secondary Ca2l signal or else some fluorescence artefact, perhaps as a consequence of cell contraction [6, 7] , is unclear. Notwithstanding this diffierence, the data obtained with fura-2 establish that both histamine and thrombin generate a similar maximum rise in [Ca2"], and that they are both acting predominantly on a single population of cells.
Inositol phosphate metabolism Having established that histamine and thrombin appeared to evoke Ca2l mobilization/influx on the same cells in our preparation (see above), the inositol phosphate profile in response to these two agonists, acting either alone or in combination, was investigated. Inositol phosphate production by HUVECs was examined at times after stimulation which would coincide with the fluorescence signal either near the peak of the transient (30 s; Fig. 1 ) or after the initial transient when Ca2+ influx could still be observed (5 min; Fig. 1) .
Incubation of HUVECs for 30 s with either histamine or thrombin caused similar increases in the accumulation of InsP1 and InsP2; in these fractions the combined increases caused by each agonist appeared to be equivalent to the accumulation when the two agonists were added together (Table 1) . Although this was most apparent in the InsP2 fractions, changes in the InsP1 fractions were not always statistically significant; the apparent increases in InsP1 and the additivity were, however, consistently observed in other experiments at 30 s. This additivity at 30 s was not seen in the InsP3 fraction (see also It would appear that the concentration of histamine used for these experiments (20 /tM) is about 90 % of maximal for this agonist [15] and, although higher doses of thrombin (10 unit/ml) caused a higher inositol phosphate production (results not shown), we were reluctant to increase the concentration of this agonist further to avoid thrombin's proteolytic activity. Also, 1 unit of thrombin/ml was maximal in evoking [3H]arachidonate release from HUVECs (results not shown). Thus we cannot say whether at maximal doses thrombin and histamine are additive (and consequently whether they have access to separate pools of inositol lipid substrate); at the concentrations used in this study, the responses to histamine and thrombin are additive at 30 s, and this provides us with a system for studying possible interactions between the two agonists.
In HUVECs that have been stimulated with either histamine or thrombin for 5 min, much larger increases were seen in the accumulation of InsP1, InsP2 and InsP3, and a small (20) (21) (22) (23) (24) (25) [28, 29] is the principal metabolic pathway in these cells, at least initially. The predominance of Ins(4)P over Ins(l)P in the presence of Li' is consistent with previous observations in, for example, human platelets [30] and GH3 cells [31] . The rapid accumulation of Ins(1,3,4)P3 [27, 33] ) and in brain [34] . We have also observed in another experiment that the peak of InsP4 activity did not exactly co-elute with an Ins(1,3,4,5)P4 standard, a result similar to that obtained by Stephens et al. [35] , and, in view of their observations, this peak is likely to be L-Ins(1,4,5,6)P4 [= Ins(3,4,5,6)-P4], a precursor in the pathway to InsP5. In summary,
HUVECs produce a complex pattern of inositol phosphate isomers, which includes InsP5 and InsP6.
Conclusions
These results confirm and extend the observations by other groups (e.g. refs. [15] [16] [17] [18] ) which demonstrate that both histamine and thrombin can stimulate inositol phosphate formation and Ca2" mobilization in HUVECs.
This study also shows, however, that these agonists are acting on the same cell population, and that their effects on inositol phosphate formation can be additive.
Our results demonstrate that quantitative analysis of InsP isomers is possible in HUVECs; how histamine and thrombin may differ in the pattern of isomers that they produce, and how these agonists interact (if at all), requires further investigation.
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